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Abstract
Diarylethenes were attached to the 5-position of 2’-deoxyuridine in order to yield three different photochromic nucleosides. All
nucleosides were characterized with respect to their absorption and photochromic properties. Based on these results, the most
promising photochromic DNA base modification was incorporated into representative oligonucleotides by using automated phos-
phoramidite chemistry. The switching of optical properties in DNA can be achieved selectively at 310 nm (forward) and 450 nm
(backward); both wavelengths are outside the normal nucleic acid absorption range. Moreover, this nucleoside was proven to be
photochemically stable and allows switching back and forth several times. These results open the way for the use of diarylethenes
as photochromic compounds in DNA-based architectures.
Introduction
The well-defined photoinduced switching of the optical and
electronic properties of molecular components represents an
increasingly significant goal for the development of new
photoreactive nanostructured architectures. Among those archi-
tectures, nucleic acids were proven to be an important scaffold
for the precise arrangement of all kinds of chromophores inside
or along the double helix [1-4]. Nucleic acids are synthesized
by building blocks; in this bottom-up approach artificial func-
tionalities, such as photoswitches, can be introduced syntheti-
cally by providing the corresponding artificial DNA building
block. Among the known and structurally diverse photochromic
compounds [5-8], azobenzenes [9], spirobenzopyrans [10] and
diarylethenes [11] represent the most promising candidates for
introducing photoswitching functionality into biopolymers, and
thereby for regulating biological activity [12,13]. Azobenzenes
were designed and synthesized as artificial photoswitchable
components in nucleic acids and are suitable for the control of a
variety of different biological functions. The photoinduced
cis–trans isomerization of azobenzene nucleosides can
reversibly switch between the formation and dissociation of
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Scheme 1: Spiropyran as DNA base surrogate 1, DNA base modifications 2 and 3, and diarylethene-modified nucleosides 4–6. Photoswitching is
representatively shown for nucleoside 4.
DNA duplexes [14-17], photoregulate DNA polymerase reac-
tion [18], photocontrol DNA triplex formation [19], and drive
photon-fueled DNA-based nanomachines [20,21].
Concerning the extent of structural change, the cis–trans
isomerization of azobenzenes behaves much simpler than the
ring opening of spiropyrans to merocyanines. In the latter case
not only is a structural change observed but a large change in
polarity is yielded additionally [10,22]. It is expected that the
ring-closed spiropyran form of this molecular switch does not
insert into the base stack due to its twisted structure, but the
open merocyanine form could intercalate based on its planarity
and polarity. This assumption was experimentally verified by
synthetic spiropyrans as noncovalent DNA and RNA binders
[23-25]. As expected, ground-state interactions between the
noncovalently bound molecular switch and the DNA bases were
detected in the case of the merocyanine form by CD spec-
troscopy, but not in the case of the spiropyran form. Attempts to
attach spiropyrans covalently to DNA are rare [26,27] and
include our recent approaches to incorporate synthetically the
spiropyran chromophore [28], by either DNA building block 1
[29] or by DNA base modifications 2 and 3 [29,30], into oligo-
nucleotides (Scheme 1). Although the spiropyran DNA building
blocks 1 and 2 exhibit promising photochromic properties as
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nucleosides, it is not worth pursuing this synthetic direction
further for the following reasons [30]: (i) It is reported that
spiropyrans decompose in aqueous buffer solutions [31], and
(according to our experience) the DNA environment does not
efficiently prevent this decomposition. (ii) Moreover, we found
out that the spiropyran chromophore in the DNA environment
loses its photoswitching abilities [29].
The second alternative, diarylethenes, have been applied for
switching the binding affinities of proteins and peptides [32] but
are still rather unexplored with respect to nucleic acids. The
advantage of this type of photoswitch is that back reaction
(reopening of the central ring) requires light and cannot be
achieved in a thermally induced way. Diarylethenes have been
applied in a noncovalent chiroptical photoswitchable DNA
complex [33] and combined with 7-deazaadenosine to obtain a
nucleosidic diarylethene switch [34]. Recently, we reported,
very preliminarily, the preparation and optical properties of
nucleoside 4 [30]. Herein, we give a full account and present
the detailed synthesis of diarylethene-modified nucleosides 4, 5
and 6  (Scheme 1), and the characterization of their
photochromic behavior. It turned out to be most promising to
continue the DNA work with the modified and photochromic
nucleoside 4, which was, thus, incorporated into representative
oligonucleotides by using automated phosphoramidite chem-
istry, and characterized with respect to its photochromism in
DNA.
Results and Discussion
Design and synthesis of diarylethene-modi-
fied 2’-deoxyuridines 4–6
The typical way to tether fluorophores to oligonucleotides is to
use an alkyl chain linker between the chromophore and DNA
base as the point of attachment. The purpose of this conforma-
tionally flexible tether is to overcome problems in the enzy-
matic activity by DNA polymerases in the context of primer-
extension (PEX) or PCR studies [35-37]. However, the shortest
possible linking of chromophores to oligonucleotides offers
potentially interesting optical characteristics, among these being
solvatochromism and red-shifted exciplex-type fluorescence
[38]. Such absorption and fluorescence readouts are potentially
suitable for DNA probing [39-41]. On the other hand, with
respect to polymerase-assisted PEX and PCR experiments, an
absolutely critical issue regarding the application of single C–C
bonds, or ethinyl or phenylene linkers is the question of whether
the canonical base-recognition complementarity is effected by
the chromophore modification [42,43]. Due to the strongest re-
activity the 5-position of pyrimidines (U/T and C) and the
8-position of purines (A and G) are preferred as chromophore
modification sites. The assumption, that these points of attach-
ment allow the chromophores to point into the major groove is
only partially true, if at all. In particular, large and aromatic
chromophores tend to insert into the base stack due to their
hydrophobicity by changing the attached nucleoside from the
natural anti- to the syn-conformation. The modification of the
8-position of purines clearly forces the nucleoside into the syn-
conformation, which interferes with Watson–Crick base pairing.
In the case of the pyrimidines the modification at position 5
should not significantly interfere with the preferred anti-con-
formation of the nucleosidic bond. Thus, the Watson–Crick
base pairing of the corresponding modified oligonucleotides
should be maintained. Over the past few years we have synthet-
ically attached various chromophores, such as ethynylpyrenes
[44,45], BODIPY [46], ethynyl nile red [47,48] and others, to
2’-deoxyuridines for electron transfer studies and for fluores-
cent probes. To gain greater insight into the counterbase selec-
tivity, we performed PEX experiments with a representative set
of chromophore-modified oligonucleotides and found that the
DNA-polymerase-catalyzed nucleotide incorporation opposite
to attached chromophores at the 5-position of uridine follows
Watson–Crick selectivity [49]. In the meantime, DNA poly-
merases have been evolved that have an increased reactivity for
C5-modified deoxyribonucleotides [50]. Hence, it looked most
reasonable to attach diarylethenes as photochromic compounds
to the 5-position of 2’-deoxyuridine. The nucleoside 4 bears the
bromine group, which was introduced initially for synthetic
reasons. In the second nucleoside 5 the bromine was replaced
by an ethynyl group. The third nucleoside 6 carries two
2’-deoxyuridine moieties and should principally allow connec-
tion of the two DNA double helices by the diarylethene linker
as a covalent bridge between.
The preparation of all three nucleosides 4 [30], 5 and 6
(Scheme 2) is based on Sonogashira-type cross couplings as key
steps [51] to attach the photoactive chromophore to the nucleo-
side. For the synthesis of the first nucleoside 4 (Scheme 2),
commercially available 5-bromobenzothiazole (7) is deproto-
nated with LDA and methylated by methyl iodide in quantitat-
ive yield. The resulting 5-bromo-2-methylbenzothiazole (8) was
converted in a double Friedel–Crafts-type acylation. Treatment
with glutaryl chloride in the presence of AlCl3 connects two
benzothiazoles 8 and provides 9 in 74% yield. The double
McMurry-type reaction, which is performed with Zn and TiCl4,
forms the central cyclopentane ring of diarylethene 10. Subse-
quently, the ethynyl linker is attached to 10 by treatment with
TMS-protected acetylene in a Pd-catalyzed cross-coupling reac-
tion. Careful evaluation of this synthetic step revealed that the
best yield (43%) of the mono-ethinylated product 11 is obtained
with 2 equiv of TMS-acetylene in the reaction mixture. The
competitively formed doubly ethinylated diarylethene 12 is, of
course, easier to obtain. In the latter case, a strong excess of
TMS-acetylene (10 equiv) helps to increase the yield of prod-
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Scheme 2: Synthesis of diarylethene-modified 2’-deoxyuridines 4 [30], 5 and 6.
uct 12 to 85%. The synthesis of the first diarylethene-modified
nucleoside 4 then continues by cleavage of the TMS protecting
group of 11 with K2CO3 in MeOH. Finally, the synthesis is
concluded by the Sonogashira-type coupling of diarylethene 13
to 5-iodo-2’-deoxyuridine (14) in 65% yield.
For the second and third modified nucleosides 5 and 6, the last
two synthetic steps are similar to those for nucleoside 4. Depro-
tection of 12 gave the doubly ethinylated diarylethene 15 in
quantitative yield. The subsequent Sonogashira coupling with
14 at rt gave the mono-nucleosidic product 5 in 23% yield, and
at 60 °C the di-nucleosidic product 6 in 35% yield.
Photochromic properties of diarylethene-
modified 2’-deoxyuridines 4–6
The photochromic properties of the modified nucleosides 4–6
were characterized by UV–vis absorption spectroscopy at rt. All
irradiations for photoswitching of the nucleosides were
performed by using a 75 W Xe arc lamp equipped with a mono-
chromator for wavelength-selective excitation. The absorption
of nucleoside 4 in the pure synthetic form (and presumably
open form) shows absorption peaks in the UV range at 242 nm
and 310 nm (Figure 1A). It is assumed that the band at 242 nm
overlays with the absorption of the uracil moiety. Hence, the
absorption side band at 310 nm should allow, at least in prin-
Beilstein J. Org. Chem. 2012, 8, 905–914.
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Figure 1: Photoswitching properties of nucleosides 4–6 (each 20 mM in MeCN, rt). Top: Irradiation of 4 at 242 nm (A, left) and irradiation of 4 alter-
nating at 242 nm and 450 nm (B, right). Middle: Irradiation of 5 at 250 nm (C, left) and irradiation of 5 alternating at 250 nm and 450 nm (D, right).
Bottom: Irradiation of 6 at 254 nm (E, left) and plots of kinetic traces of absorption changes at 450 nm of all nucleosides 4–6 irradiated at the corres-
ponding wavelength until 30 min, then at 450 nm (F, right).
cipal, the selective excitation of the switch, outside the nucleic
acid absorption range. Accordingly, the photoswitching of 4
was probed at 242 and 310 nm. In fact, by irradiation at either
wavelength the closed form of nucleoside 4 is formed with its
characteristic band at 450 nm in the visible range. The color of
the samples turns yellow. However, the differences in the
absorption changes indicate that especially the contribution of
the colored closed form of 4 in the photostationary state by
excitation at 310 nm is less than at 242 nm (Figure 1F). Hence it
can be concluded, that the band at 310 nm can be used indeed to
Beilstein J. Org. Chem. 2012, 8, 905–914.
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excite selectively the diarylethene chromophore in nucleic
acids, but the yield of the colored form is reduced. In all cases,
the photostationary state was reached in 30 min since no addi-
tional changes were observed after that time. The absorption
bands of the open and closed forms of 4 overlap in the UV
range, which makes a detailed analysis of the photostationary
state impossible. Irradiation of the sample at 450 nm reopens
the diarylethene 4 within a few minutes. The absorption spectra
of 4 during all irradiations show an isosbestic point at 275 nm.
As expected, the thermally induced opening of the closed chro-
mophore in nucleoside 4 was never observed. The diarylethene
nucleoside 4 stays chemically and photochemically stable and
can be switched several times to the closed form, and back to
the opened form (Figure 1B).
At first glance, the photochromic properties of the second
nucleoside (5) are very similar to those of 4 (Figure 1C).
However, a careful look at the absorption changes performed at
250 nm reveals that the isosbestic point between the closed and
the opened form of nucleoside 5 has moved bathochromically
from 275 to 300 nm. Moreover, the closed form does not only
show an increased absorption in the visible range at 450 nm but
also a more significant contribution to the absorption in the UV
range at 310 nm. As a result, photoswitching from the opened
form of 5 to the closed form at 310 nm cannot be performed in
an efficient way. This result is in contrast to that for the first di-
arylethene-modified nucleoside 4 described above and limits
the applicability of nucleoside 5 significantly as a photochromic
switch in nucleic acids. The diarylethene 5 can be switched
several times back and forth; however, the photochemical
stability is slightly reduced compared to nucleoside 4
(Figure 1D).
A rather dramatic change of photochromic properties is
observed upon comparison of nucleosides 4 and 5 with the third
one (6). The synthetically obtained and thereby purely closed
form of diarylethene 6 shows absorption at 254 and 350 nm
(Figure 1E). Irradiation at 250 nm indeed shows the formation
of the colored form at 450 nm, but to a much smaller extent
when compared with 4 or 5. Obviously, the conjugation of the
terminal acetylene group of nucleoside 5 to a second
2’-deoxyuridine in 6 affects its photochromism significantly
and reduces its photoswitching abilities.
Synthesis and photochromic properties of
DNA modified with diarylethene 4
As mentioned in the introduction, in a bottom-up approach
nucleic acids can be modified with artificial functionalities by
providing the corresponding synthetic building blocks. Based
on the previously described results regarding the photochromic
properties of nucleosides 4 [30], 5 and 6 it appeared to be most
promising to incorporate synthetically the nucleoside 4 into
oligonucleotides. It is the only diarylethene that allows selec-
tive excitation at 310 nm, outside of the absorption range of
DNA. The preparation of the corresponding phosphoramidite 17
as an artificial DNA building block follows standard pro-
cedures (Scheme 3) [30]: Protection of the 5’-OH group of
nucleoside 4 by DMT-chloride is followed by phosphitylation
of the 3’-OH group of the intermediate 16 yielding phosphor-
amidite 17. By automated DNA synthesis on a solid phase we
prepared a set of four oligonucleotides in order to report prelim-
inarily the optical properties of 4 in DNA. The sequences were
identical except for the base pairs that surround the position of
nucleoside 4. The oligonucleotides were purified by semi-
preparative HPLC, identified by mass spectrometry and quanti-
fied by their extinction coefficient at 260 nm.
Irradiation of each of the four single-stranded oligonucleotides
DNA1–DNA4 at 310 nm yields the characteristic absorption of
the closed forms as small and broad bands at ~450 nm, and ir-
radiation at this wavelength drives the reaction back toward the
open form of the switch (representatively shown for DNA2 in
Figure 2). The most remarkable result is that of DNA2 bearing
two guanines in the direct vicinity of the diarylethene modifica-
tion. Guanine is known to interfere with a variety of photophys-
ical properties (mainly fluorescence) in DNA. It is important to
mention here that guanine does not influence the photochromic
properties of the diarylethene switch 4 as a DNA modification.
In fact, the photoswitching behavior of 4 is maintained in all
four different DNA environments. The sequence independent
photochromic behavior represents an important result for the
future application of this type of switch in DNA-based nano-
structures. Representatively, we performed switching experi-
ments with the double strand (ds) of the most critical candidate
(DNA2). The kinetic behavior of the opening and closing of
nucleoside 4 cannot be directly compared to dsDNA2 since the
solvents in the two measurements are different. However, the
photochromic switching is clearly observable in the absorption
spectra (Figure 2A and 2B) and is very similar to that of the
single strand. Double-stranded DNA2, with the diarylethene
switch in the opened form, exhibits a melting temperature of
60.6 °C and shows a high destabilization according to the
unmodified double strand (68.0 °C). After irradiation at 310 nm,
the melting temperature decreases significantly to 56.8 °C.
According to the noncovalently bound diarylethene derivative
as chiroptical switch published by Feringa and coworkers [33],
the closed form is able to intercalate whereas the open form of
the switch binds differently. This could potentially explain the
difference in melting temperature for dsDNA2, since the inter-
calated closed form of the diarylethene interferes with stacking
to the neighboring bases by the two methyl groups pointing up
and down from the chromophore.
Beilstein J. Org. Chem. 2012, 8, 905–914.
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Scheme 3: Synthesis of DNA building block 17 [30] and sequences of diarylethene-modified DNA1–DNA4.
Figure 2: Irradiation of dsDNA2 at 310 nm (A, left) and plot of kinetic trace of absorption changes at 450 nm of dsDNA2 irradiated at 310 nm until
30 min, then 450 nm (B, right).
Conclusion
Three different diarylethene-modified 2‘-deoxyuridines 4–6
were prepared by using Sonogashira-type cross couplings as
key steps. The photochromic properties of the nucleosides were
evaluated and revealed that only nucleoside 4 allows selective
excitation at 310 nm, outside the nucleic acid absorption
window, to close the diarylethene chromophore. Switching back
of the colored form of all three nucleosides 4–6 to the corres-
ponding opened forms can be achieved by selective excitation
at 450 nm. Moreover, nucleoside 4 was proven to be photo-
chemically stable and, hence, allows switching back and forth
several times. Nucleoside 4 was incorporated into oligo-
nucleotides by automated DNA synthesis. It is remarkable that
the photochromic properties of 4 are maintained for the corres-
ponding base modification in oligonucleotides and show
sequence-independent switching behavior. Our results open the
Beilstein J. Org. Chem. 2012, 8, 905–914.
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way for the use of diarylethenes as photochromic compounds in
DNA-based architectures and represent one important step
further for the design and synthesis of photoreactive and self-
assembled nanostructures and materials based on nucleic acids.
Experimental
Materials and methods
Chemicals were purchased from Sigma Aldrich, Fluka, ABCR,
Alfa Aesar and Acros. Unmodified oligonucleotides were
purchased from Metabion. TLC was performed on Merck silica
gel 60 F254 coated aluminum foil. Flash chromatography was
carried out with silica gel 60 from Aldrich (60–73 µm). Spec-
troscopic measurements and the melting points were recorded
on a Varian Cary 100 spectrometer in quartz-glass cuvettes. Ir-
radiation experiments were performed with a 75 W Xe arc lamp
equipped with a monochromator. The synthetic procedures for
compounds 4, 8, 9, 10, 11, 13, 16 and 17 have been already
described in [30].
Compound 12: 10 (617 mg, 1.19 mmol), trimethylsilylacetyl-
ene (1.68 mL, 11.90 mmol), dry NEt3 (0.39 mL, 4.76 mmol),
Pd(PPh3)4 (550 mg, 0.48 mmol) and CuI (91 mg, 0.48 mmol)
were dissolved in dry THF (11 mL) under argon. The mixture
was degassed and heated under reflux for 20 h. After cooling to
rt, the solvent was removed under reduced pressure. The residue
was dried in vacuo and purified by flash chromatography on
silica gel (hexanes–toluene 100:1) to yield 559 mg 12 (85%) as
a white solid. Rf 0.20 (hexanes); 
1H NMR (300 MHz, CDCl3) δ
7.72 (s, 2H, H-Ar), 7.56 (d, J = 7.9 Hz, 2H, H-Ar), 7.30 (d, J =
6.9 Hz, 2H, H-Ar), 3.20–2.80 (m, 4H, CH2), 2.31 (p, J =
6.8 Hz, 2H, CH2), 1.99 (s, 6H, CH3), 0.30 (s, 18H, Si(CH3)3);
13C NMR (75 MHz, CDCl3) δ 139.3 (Cquart.), 138.7 (Cquart.),
137.5 (Cquart.), 137.1 (Cquart.), 130.2 (Cquart.), 127.1 (Carom.),
126.1 (Carom.), 121.9 (Carom.), 118.7 (Carom.), 106.0 (C≡C),
37.9 (CH2), 29.9 (C≡C), 24.3 (CH2), 15.4 (CH3), 0.3
(Si(CH3)3); EIMS (70 eV) m/z  (%): 552.2 (8) [M]
+;
HRMS–ESI (m/z): [M]+ calcd for C33H36S2Si2, 552.1797;
found, 552.1794.
Compound 15: 12 (408 mg, 0.74 mmol) was dissolved in dry
MeOH (15 mL), and K2CO3 (408 mg, 2.95 mmol) was added.
The reaction mixture was stirred for 20 h at 40 °C. After
cooling to rt, MeOH was removed under reduced pressure. The
residue was dried in vacuo and purified by flash chromatog-
raphy on silica gel (hexanes–toluene 10:1) yielding 299 mg 15
(99%) as a white solid. Rf 0.41 (hexanes–toluene 10:1);
1H NMR (400 MHz, CDCl3) δ 7.75 (s, 2H, H-Ar), 7.57 (s, 2H,
H-Ar), 7.31 (s, 2H, H-Ar), 3.08 (s, 2H, C≡CH), 3.01–2.77 (m,
4H, CH2), 2.28 (p, J = 7.3 Hz, 2H, CH2), 1.96 (s, 6H, CH3);
13C NMR (101 MHz, CDCl3) δ 139.3 (Cquart.), 138.9 (Cquart.),
137.1 (Cquart.), 130.0 (Cquart.), 128.5 (Cquart.), 126.8 (Carom.),
126.4 (Carom.), 122.0 (Carom.), 117.6 (Carom.), 76.4 (C≡C), 37.9
(CH2), 29.9 (C≡C), 24.2 (CH2), 15.2 (CH3); EIMS (70 eV) m/z
(%): 408.1 (48) [M]+.
Compound 5: 15 (75 mg, 0.18 mmol), 5-iodo-2’-deoxyuridine
(14, 65 mg, 0.18 mmol), dry NEt3 (30 µL, 0.37 mmol),
Pd(PPh3)4 (42 mg, 0.04 mmol) and CuI (7 mg, 0.04 mmol)
were dissolved in dry DMF (7 mL). The mixture was degassed
and stirred for 48 h at rt. The solvent was removed under
reduced pressure and the residue was dried in vacuo and puri-
fied by flash chromatography on silica gel (CH2Cl2–MeOH
10:1) yielding 27 mg 5 (23%) as a white solid. Rf 0.53
(CH2Cl2–MeOH 5:1); 
1H NMR (300 MHz, CDCl3) δ 8.01 (s,
1H, NH), 7.82 (s, 1H, C=CH), 7.70 (s, 2H, H-Ar), 7.55 (d, J =
7.8 Hz, 2H, H-Ar), 7.36 (s, 2H, H-Ar), 6.22 (t, J = 6.0 Hz, 1H,
1’-H), 4.62 (s, 1H, 3’-H), 4.16–4.02 (m, 1H, 4’-H), 4.00–3.85
(m, 2H, 5’-H), 3.08 (s, 1H, C≡CH), 3.02–2.72 (m, 4H, CH2),
2.40 (s, 1H, 2’-H), 2.26 (s, 2H, CH2), 2.05–1.79 (m, 7H, CH3,
2’-H); 13C NMR (75 MHz, CDCl3) δ 154.2, 142.7, 141.4,
140.1, 138.9, 138.6, 137.2, 130.0, 127.1, 127.0, 121.6, 118.0,
106.1, 90.4, 88.1, 77.3, 72.8, 64.0, 42.5, 38.5, 24.9, 15.0;
MALDI–MS m/z (%): 633.6 (5) [M]+; HRMS–ESI (m/z): [M +
H]+ calcd for C36H31N2O5S2, 635.1674; found, 635.1681.
Compound 6: 15 (81 mg, 0.20 mmol), 5-iodo-2’-deoxyuridine
(14, 140 mg, 0.40 mmol), dry NEt3 (30 µL, 0.40 mmol),
Pd(PPh3)4 (46 mg, 0.04 mmol) and CuI (8 mg, 0.04 mmol)
were dissolved in dry DMF (7 mL). The mixture was degassed
and stirred for 3 h at 60 °C. After cooling to rt, the solvent was
removed under reduced pressure, and the residue was dried in
vacuo and purified by flash chromatography on silica gel
(CH2Cl2–MeOH 15:1) to yield 60 mg 6 (35%) as a white solid.
Rf 0.55 (CH2Cl2–MeOH 10:1); 
1H NMR (400 MHz, DMSO-d6)
δ 8.87 (s, 1H, NH), 8.38 (s, 1H, NH), 7.97 (s, 2H, C=CH), 7.85
(d, J = 9.3 Hz, 2H, H-Ar), 7.80–7.52 (m, 4H, H-Ar), 6.31–6.02
(m, 2H, 1’-H), 5.31 (d, J = 10.7 Hz, 2H, 3’-H), 5.24–5.08 (m,
2H, 4’-H), 4.27 (s, 2H, 5’-H), 3.94–3.83 (m, 2H, 5’-H),
3.79–3.43 (m, 4H, CH2), 3.17–3.13 (m, 2H, 2’-H), 3.00–2.67
(m, 10H, 2’-H, CH2, CH3); 
13C NMR (101 MHz, DMSO-d6) δ
161.4, 153.9, 149.4, 137.5, 136.2, 130.3, 130.0, 129.6, 122.8,
120.1, 117.9, 117.6, 106.9, 99.5, 99.2, 98.3, 88.2, 87.6, 84.8,
70.1, 69.5, 60.9, 60.7, 45.6, 37.5, 29.0, 28.7, 23.4, 22.1, 15.0.
MS–FAB m/z (%): 883.4 (25) [M + Na]+; HRMS–ESI (m/z):
[M + H]+ calcd for C45H41N4O10S2, 861.2264; found,
861.2282.
DNA synthesis: Oligonucleotides were prepared with an
Expedite 8909 Synthesizer from ABI by using standard phos-
phoramidite chemistry. Reagents and CPGs were purchased
from ABi and Glen research. Modified oligonucleotides were
synthesized by a modified protocol. The activator solution
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(0.45 M tetrazole in MeCN) was pumped simultaneously with
the building block 17 [30] and the coupling time was extended
to 35 min, with an intervening step after 17.5 min for washing
and refreshing of the activator–17 solution. After coupling, the
vial was washed with MeCN. When the synthesis was complete
the trityl-on oligonucleotides were treated with conc. NH4OH
(700 μL, >25%, trace select, Fluka) at 55 °C for 14 h for
cleavage from the resin for deprotection. The oligonucleotides
were purified by HPLC on a semipreparative RP-18 column
(300 Å, Supelco) by using NH4OAc buffer (pH = 6.5) and
MeCN as eluents (0–20% MeCN over 70 min; flow rate:
2.5 mL; UV detection: 260 nm, 310 nm). To cleave the terminal
DMT group the oligonucleotides were treated with 80% acetic
acid for 1 h at rt. After removal of the solvent, the residue was
redissolved in H2O and the emerging precipitate was removed.
The oligonucleotides were lyophilized and quantified by their
absorbance in H2O at 260 nm on a Varian Cary 100 spectrom-
eter, including ε260 = 56200 M
−1 cm−1 for modification S
(Scheme 3). dsDNA1 was formed by heating to 90 °C (10 min)
followed by slow cooling to rt. MALDI–MS DNA1 m/z (%):
5898.9 (100) [M + DMT]−, 5597.3 (99) [M]−, 2949.2 (21) [M +
DMT]−/2, 2797.7 (20) [M]2−/2; DNA2 m/z (%): 5950.0 (100)
[M + DMT]−, 5647.9 (38) [M]−, 2974.6 (17) [M + DMT]2−/2,
2823.6 (7) [M]2−/2; DNA3 m/z (%): 5869.0 (100) [M + DMT]−,
5666.8 (58) [M]−, 2944.4 (12) [M + DMT]2−/2, 2782.6 (12)
[M]2−/2; DNA4 m/z (%): 5919.9 (100) [M + DMT]−, 5617.7
(34) [M]−, 2957.7 (25) [M + DMT]2−/2, 2808.9 (6) [M]2−/2.
The UV–vis absorption spectra of ssDNA1–ssDNA4 are shown
in Figure 3.
Figure 3: UV–vis absorption spectra of ssDNA1–ssDNA4 (2.5 μM in
50 mM Na–Pi buffer, pH 7, 250 mM NaCl, rt).
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